Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction

被引:45
|
作者
Sartipy, Ulrik [1 ,2 ]
Savarese, Gianluigi [3 ]
Dahlstrom, Ulf [4 ,5 ]
Fu, Michael [6 ]
Lund, Lars H. [1 ,3 ]
机构
[1] Karolinska Univ Hosp, Heart & Vasc Theme, SE-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[3] Karolinska Inst, Dept Med, Stockholm, Sweden
[4] Linkoping Univ, Dept Cardiol, Linkoping, Sweden
[5] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden
[6] Sahlgrens Univ Hosp, Dept Med, Ostra Hosp, Gothenburg, Sweden
关键词
Heart failure with preserved ejection fraction; Atrial fibrillation; Sinus rhythm; Heart rate; Mortality; Registry; BETA-BLOCKERS; PROGNOSTIC-SIGNIFICANCE; OUTCOMES; RISK; DYSFUNCTION; MORBIDITY; MIDRANGE; SPECTRUM; TRIAL;
D O I
10.1002/ejhf.1389
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsTo assess the association between atrial fibrillation (AF) and mortality, and also the association between resting heart rate (HR) and mortality in both sinus rhythm (SR) and AF in patients with heart failure with preserved ejection fraction (HFpEF). Methods and resultsA total of 9090 patients with HFpEF (ejection fraction 50%) were included from the Swedish Heart Failure registry; 4296 (47%) had SR and 4794 (53%) had AF. Patients with AF were older (80.3 vs. 75.0years) and more symptomatic compared with patients in SR. The outcome measure was all-cause mortality. The adjusted hazard ratio (95% confidence interval) for AF vs. SR was 1.21 (1.11-1.32). Compared with HR 60b.p.m., the adjusted hazard ratios (95% confidence interval) were in SR: 1.06 (0.92-1.21) for HR 61-70b.p.m., 1.30 (1.12-1.52) for HR 71-80b.p.m., 1.27 (1.07-1.51) for HR 81-90b.p.m., and 1.77 (1.45-2.17) for HR >90b.p.m. Due to non-proportional hazards in AF, hazard ratios were estimated in three time periods. Compared with HR 60 b.p.m., the adjusted hazard ratios (95% confidence interval) were in AF: 1.30 (1.07-1.57), 1.07 (0.83-1.39), and 1.01 (0.70-1.48) for HR 61-70b.p.m., 1.35 (1.12-1.62), 0.99 (0.77-1.27), and 0.96 (0.66-1.40) for HR 71-80b.p.m., 1.41 (1.16-1.73), 1.01 (0.76-1.36), and 0.79 (0.51-1.22) for HR 81-90b.p.m., and 1.78 (1.46-2.17), 1.08 (0.80-1.46), and 0.73 (0.46-1.17) for HR >90b.p.m., during 0-2, 2-4, and 4-6years of follow-up, respectively. ConclusionIn a large and unselected cohort of patients with HFpEF, AF was independently associated with all-cause mortality. A higher HR was associated with increased mortality in SR. In AF, the effect of a higher HR on mortality was only present during the first years of follow-up, with convergence in outcomes according to baseline HR groups over long-term follow-up.
引用
收藏
页码:471 / 479
页数:9
相关论文
共 50 条
  • [21] Left atrial function and atrial fibrillation in heart failure with preserved ejection fraction
    Schoenbauer, R.
    Kammerlander, A. A.
    Duca, F.
    Aschauer, S.
    Binder, C.
    Zotter-Tufaro, C.
    Fiedler, L.
    Roithinger, F. X.
    Loewe, C.
    Hengstenberg, C.
    Bondermann, D.
    Mascherbauer, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 49 - 49
  • [22] Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
    Gierula, John
    Cole, Charlotte A.
    Drozd, Michael
    Lowry, Judith E.
    Straw, Sam
    Slater, Thomas A.
    Paton, Maria F.
    Byrom, Rowenna J.
    Garland, Ellis
    Halliday, Georgia
    Winsor, Sarah
    Lyall, Gemma K.
    Birch, Karen
    McGinlay, Melanie
    Sunley, Emma
    Grant, Peter J.
    Wessels, David H.
    Ketiar, Elias M.
    Witte, Klaus K.
    Cubbon, Richard M.
    Kearney, Mark T.
    ESC HEART FAILURE, 2022, 9 (05): : 3254 - 3263
  • [23] Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation
    Filippatos, Gerasimos
    Farmakis, Dimitrios
    Butler, Javed
    Zannad, Faiez
    Ferreira, Joao Pedro
    Ofstad, Anne Pernille
    Iwata, Tomoko
    Brueckmann, Martina
    Pocock, Stuart J.
    Packer, Milton
    Anker, Stefan D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (07) : 970 - 977
  • [24] Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction The TOPCAT Trial
    Cikes, Maja
    Claggett, Brian
    Shah, Amil M.
    Desai, Akshay S.
    Lewis, Eldrin F.
    Shah, Sanjiv J.
    Anand, Inder S.
    O'Meara, Eileen
    Rouleau, Jean L.
    Sweitzer, Nancy K.
    Fang, James C.
    Saksena, Sanjeev
    Pitt, Bertram
    Pfeffer, Marc A.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2018, 6 (08) : 689 - 697
  • [25] Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
    Tica, Otilia
    Khamboo, Waseem
    Kotecha, Dipak
    CARDIAC FAILURE REVIEW, 2022, 8
  • [26] Prevalence of Subclinical Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction
    Yang, Eunice
    Heckbert, Susan R.
    Ding, Jennifer
    Spragg, David
    Calkins, Hugh
    Shah, Sanjiv
    Szklo, Moyses
    Post, Wendy S.
    Sharma, Kavita
    JACC-HEART FAILURE, 2024, 12 (03) : 492 - 504
  • [27] Subclinical Heart Failure With Preserved Ejection Fraction in Patients With Atrial Fibrillation
    Dai, Zhehao
    JACC-HEART FAILURE, 2024, 12 (02) : 421 - 422
  • [28] Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation Vicious Twins
    Kotecha, Dipak
    Lam, Carolyn S. P.
    Van Veldhuisen, Dirk J.
    Van Gelder, Isabelle C.
    Voors, Adriaan A.
    Rienstra, Michiel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (20) : 2217 - 2228
  • [29] Effects of rhythm control on left atrial structure remodeling in atrial fibrillation and heart failure with preserved ejection fraction
    Bai, Lin
    Sun, Yuxi
    Si, Jiping
    Ding, Zijie
    Zhang, Xinxin
    Zhang, Yanli
    Xia, Yunlong
    Liu, Ying
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [30] THE IMPACT OF LEFT ATRIAL FUNCTION AND SINUS RHYTHM ON EXERCISE HEMODYNAMICS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Reddy, Yogesh N. V.
    Obokata, Masaru
    Borlaug, Barry
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 914 - 914